Incidence of a clinical diagnosis of the irritable bowel syndrome in a United States population

Alimentary Pharmacology and Therapeutics

Volumn 19, Issue 9, 2004, Pages 1025-1031

  Locke III, G R ^a   Yawn, B P ^b   Wollan, P C ^b   Melton III, L J ^a   Lydick, E ^c   Talley, N J ^a  

^a MAYO CLINIC   (United States)

^b OLMSTED MEDICAL CENTER   (United States)

^c SmithKline Beecham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ADULT; AGED; CLINICAL FEATURE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; FEMALE; HUMAN; INCIDENCE; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; OUTCOMES RESEARCH; PHYSICIAN; PRIORITY JOURNAL; REVIEW; SEX RATIO; SYMPTOM; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; MINNESOTA; REGRESSION ANALYSIS; SEX DISTRIBUTION;

EID: 2442651266     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.01938.x     Document Type: Review

References (26)

1. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999; 45 (Suppl. 2): II43-7.
2. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123: 2108-31.
3. Talley NJ, Zinsmeister AR, Melton LJ III. Irritable bowel syndrome in a community: symptom subgroups, risk factors and health care utilization. Am J Epidemiol 1995; 142: 76-83.
4. Drossman DA, Li Z, Andruzzi E, et al. U. S. householder survey of functional gastrointestinal disorders. Prevalence sociodemography, and health impact. Dig Dis Sci 1993; 38: 1569-80.
5. Yawn BP, Locke GR III, Lydick E, Wollan PC, Bertram SL, Kurland MJ. Diagnosis and care of irritable bowel syndrome in a community based population. Am J Manag Care 2001; 7: 585-92.
6. Yawn BP, Lydick E, Locke GR, Wollan PC, Bertram SL, Kurland MJ. Do published guidelines for evaluation of irritable bowel syndrome reflect practice? BMC Gastroenterology 2001; 1: 11.
7. Talley NJ, Gabriel SE, Harmsen WS, Zinsmeister AR, Evans RW. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995; 109: 1736-41.
8. Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002; 122: 1500-11.
9. Saito YA, Schoenfeld P, Locke GR III. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002; 97: 1910-5.
10. Muller-Lissner SA, Bollani S, Brummer RJ, et al. Epidemiological aspects of irritable bowel syndrome in Europe and North America. Digestion 2001; 64: 200-4.
11. Brandt LJ, Bjorkman D, Fennerty MB, et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol 2002; 97(Suppl.): S7-26.
12. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ III. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992; 136: 165-77.
13. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996; 71: 266-74.
14. Schroeder DJ, Offord KP. A SAS Macros which Utilizes Local and Reference Population Counts Appropriate for Incidence, Prevalence, and Mortality Rate Calculations in Rochester and Olmsted County, Minnesota. Technical Report Series 1982; No. 20: Section of medical research statistics. Rochester, MN, USA: Mayo Clinic, August 1982.
15. Agreus L, Svardsudd K, Nyren O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995; 109: 671-80.
16. Koloski NA, Talley NJ, Boyce PM. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors. Am J Gastroenterol 2001; 96: 1340-9.
17. Rodriguez G, Ruigomez LA, Wallander MA, Johansson S, Olbe L. Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome. Scand J Gastroenterol 2000; 35: 306-11.
18. Hamm LR, Sorrells SC, Harding JP, et al. Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria. Am J Gastroenterol 1999; 94: 1279-82.
19. Cash BD, Schoenfeld P, Chey WD. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol 2002; 97: 2812-9.
20. Rex DK. Rationale for colonoscopy screening and estimated effectiveness in clinical practice. Gastrointest Endosc Clin N Am 2002; 12: 65-75.
21. Loftus EV JR, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther 2002; 16: 51-60.
22. Talley NJ, O'Keefe EA, Zinsmeister AR, Melton LJ III. Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology 1992; 102: 895-901.
23. Ruigomez A, Wallander MA, Johansson S, Garcia Rodriguez LA. One-year follow-up of newly diagnosed irritable bowel syndrome patients. Aliment Pharmacol Ther 1999; 13: 1097-102.
24. Camilleri M, Lee JS, Viramontes B, Bharucha AE, Tangalos EG. Insights into the pathophysiology and mechanisms of constipation, irritable bowel syndrome, and diverticulosis in older people. J Am Geriatr Soc 2000; 48: 1142-50.
25. Zuckerman MJ, Guerra LG, Drossman DA, Poland JA, Gregory GG. Comparison of bowel patterns in Hispanics and non-Hispanic whites. Dig Dis Sci 1995; 40: 1763-9.
26. Talley NJ, Spiller R. Irritable bowel syndrome: a little understood organic bowel disease? Lancet 2002; 360: 555-64.